Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
XIX, 601 p. Cloth. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Sprache: Englisch.
EUR 78,71
Anzahl: 4 verfügbar
In den WarenkorbZustand: New. pp. x + 601.
Sprache: Englisch
Verlag: Springer Publishing Company, New York, 2008
ISBN 10: 0387715177 ISBN 13: 9780387715179
Anbieter: San Francisco Book Company, Paris, Frankreich
Hardcover. Zustand: Very good. Cloth/no dust jacket Quarto. black cloth, silver lettering, 601 pp Standard shipping (no tracking) / Priority (with tracking) / Custom quote for large or heavy orders.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Dr. Judah Folkman, 'father of angiogenesis', (1933-2008) was the Director of the Vascular Biology Program, Andrus Professor of Pediatric Surgery, and Professor of Cell Biology at Harvard University's Boston Children's Hospital. In the 1971 issue of The New England Journal of Medicine, he proposed the theory that tumor growth is angiogenesis dependent. This premise was the basis of this field of research and has become the focus of scientists worldwide. Because of Folkman's discovery and research, the possibilities of antiangiogenic and angiogenic therapy have broadened beyond cancer to many noncancerous diseases.This book represents the first collection in a volume of which Dr. Folkman is co-editor. Dr. Folkman authored nearly 400 original papers and more than 100 book chapters.Dr. William Figg is the chief of the Molecular and Clinical Pharmacology Program at the National Cancer Institute, National Institutes of Health. Over the past 15 years, his laboratory and clinic at the NCI have focused on the development of angiogenesis inhibitors. Dr. Figg has published more than 380 publications.